The division of vascular surgery at the University of Florida conducts clinical and outcomes research related to treatment of complex thoracic and abdominal aortic disease, as well as carotid artery and peripheral vascular disease. Our surgeons are facilitating a number of clinical trials for the treatment of those conditions.
They also are investigating ways to predict and treat spinal cord ischemia, the restriction of blood flow to an area due to a blocked or narrowed vessel, after open and endovascular treatment of aortic aneurysm and dissection.
Adam Beck, M.D., leads the way in the division’s efforts to improve the quality of vascular surgery throughout the state of Florida. Beck is working with other surgeons around the state to develop a vascular surgery study group that will operate in conjunction with the Vascular Study Group of New England. The purpose of this group will be to examine results after vascular procedures at a regional level and determine ways to collectively improve the care of vascular patients in Florida.
Ongoing clinical trials related to the division’s clinical and outcomes research:
- Medtronic THRIVE- Post-market trial for the Medtronic Talent Thoracic device
- Cook Zenith TX2- Post-market trial for the TX2 thoracic device for thoracic aneurysm
- Cook Zenith TX2 Aortic dissection trial
- Medtronic Talent Aortic dissection trial
- Medtronic Talent Aortic transection trial
- Bolton RELAY thoracic aortic device trial for thoracic aneurysm
- Lombard Aorfix PYTHAGORAS high angle aortic neck infrarenal aortic device trial
- Cook Zenith Low Profile abdominal aortic aneurysm device trial
- Abbott CHOICE study for high risk carotid stenting